Clinical Trials for Tella

Explore 150 clinical trials worldwide

Showing 1-50 of 150 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Tella

Clinical Trials (150)

NCT07207213
SOCIAL: Adaptation and Validation of the In-person PEERS® Program for Adolescents With Autism.
NANot yet recruiting
36 participants
Started: Jan 1, 2026 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT07139977
Study of EV for Recurrent Endometrial Carcinoma
PHASE2Not yet recruiting
12 participants
Started: Nov 1, 2025 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT06917313
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
PHASE2Not yet recruiting
92 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT07110038
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
PHASE2Not yet recruiting
25 participants
Started: Oct 31, 2025 · Completed: Nov 30, 2030
1 condition4 sponsors1 location
NCT07101185
Transition to Adulthood in People With Muscular Dystrophy
NANot yet recruiting
250 participants
Started: Sep 30, 2025 · Completed: Aug 31, 2027
1 condition20 sponsors1 location
NCT07092436
Pediatric Upper-Limb Rehabilitation With PhiCube, a Modular Bilateral End-Effector Device
NANot yet recruiting
54 participants
Started: Sep 30, 2025 · Completed: Oct 31, 2026
2 conditions6 sponsors0 locations
NCT06396091
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer
PHASE1Recruiting
12 participants
Started: Sep 24, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor7 locations
NCT06956209
Akyva First In Human
NARecruiting
10 participants
Started: Sep 24, 2025 · Completed: Mar 31, 2027
1 condition3 sponsors1 location
NCT07140016
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
PHASE1Recruiting
40 participants
Started: Sep 22, 2025 · Completed: Dec 31, 2029
2 conditions1 sponsor2 locations
NCT07052929
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
PHASE1/PHASE2Recruiting
9 participants
Started: Sep 11, 2025 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT07064226
Validation of a Digital Intervention to Rehabilitate Cognitive Resources
NANot yet recruiting
102 participants
Started: Sep 10, 2025 · Completed: Sep 30, 2027
3 conditions3 sponsors1 location
NCT06957691
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
PHASE2Not yet recruiting
60 participants
Started: Aug 31, 2025 · Completed: Dec 31, 2028
19 conditions2 sponsors0 locations
NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
PHASE1Recruiting
364 participants
Started: Jul 25, 2025 · Completed: Apr 30, 2029
4 conditions1 sponsor4 locations
NCT07086651
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
N/ARecruiting
1,300 participants
Started: Jul 21, 2025 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT07024615
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
PHASE1Recruiting
25 participants
Started: Jul 16, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor2 locations
NCT07063030
A Study of LX107 Gene Therapy in AIPL1-IRD Patients
EARLY_PHASE1Not yet recruiting
13 participants
Started: Jul 15, 2025 · Completed: Dec 31, 2030
1 condition2 sponsors0 locations
NCT06970665
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
PHASE4Recruiting
20 participants
Started: Jul 8, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor12 locations
NCT07053358
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
EARLY_PHASE1Recruiting
10 participants
Started: Jul 2, 2025 · Completed: Dec 30, 2029
1 condition2 sponsors1 location
NCT06783010
Development of an Ensemble Learning-based, Multi-dimensional Sensory Impairment Score to Predict Cognitive Impairment in an Elderly Cohort of Southern Italy
N/ANot yet recruiting
30 participants
Started: Jun 30, 2025 · Completed: Jan 10, 2026
3 conditions3 sponsors0 locations
NCT06862219
A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer
PHASE4Recruiting
100 participants
Started: Jun 21, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors7 locations
NCT07005154
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
PHASE2Recruiting
218 participants
Started: Jun 19, 2025 · Completed: May 31, 2032
3 conditions1 sponsor4 locations
NCT06906822
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
PHASE2Recruiting
60 participants
Started: Jun 10, 2025 · Completed: Jun 30, 2028
1 condition3 sponsors13 locations
NCT06901531
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
PHASE3Recruiting
500 participants
Started: May 22, 2025 · Completed: Dec 31, 2029
4 conditions1 sponsor78 locations
NCT06581146
A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
N/ARecruiting
50 participants
Started: May 19, 2025 · Completed: May 31, 2027
1 condition1 sponsor3 locations
NCT06603987
Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
PHASE1/PHASE2Enrolling by invitation
30 participants
Started: Apr 10, 2025 · Completed: Oct 31, 2028
1 condition3 sponsors1 location
NCT06809140
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
PHASE2Recruiting
47 participants
Started: Apr 7, 2025 · Completed: Nov 30, 2029
1 condition5 sponsors3 locations
NCT06902545
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.
N/ARecruiting
377 participants
Started: Apr 3, 2025 · Completed: Jul 31, 2030
4 conditions1 sponsor10 locations
NCT06470282
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
47 participants
Started: Mar 31, 2025 · Completed: Jan 31, 2028
4 conditions3 sponsors1 location
NCT06891560
A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma
PHASE2Recruiting
34 participants
Started: Mar 31, 2025 · Completed: Mar 31, 2027
1 condition2 sponsors7 locations
NCT06553885
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
PHASE2Recruiting
40 participants
Started: Mar 24, 2025 · Completed: Sep 30, 2029
2 conditions2 sponsors1 location
NCT06812754
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause
PHASE2Recruiting
150 participants
Started: Mar 10, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor27 locations
NCT06779773
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
N/ARecruiting
1,000 participants
Started: Jan 22, 2025 · Completed: Jan 31, 2030
2 conditions1 sponsor45 locations
NCT06130995
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
PHASE1Recruiting
46 participants
Started: Dec 26, 2024 · Completed: Jan 31, 2030
2 conditions3 sponsors1 location
NCT06826287
7T Anatomo-functional Characterization of Structures in the Action Observation Network
N/ARecruiting
40 participants
Started: Dec 2, 2024 · Completed: Aug 9, 2025
2 conditions3 sponsors2 locations
NCT06797050
A Story for Pepper & Nao
NAActive, not recruiting
80 participants
Started: Dec 1, 2024 · Completed: Apr 1, 2026
1 condition4 sponsors3 locations
NCT05656235
Renal Retention in High Grade Upper Tract Urothelial Cancer
PHASE2Recruiting
20 participants
Started: Nov 25, 2024 · Completed: Jun 30, 2029
3 conditions4 sponsors2 locations
NCT06666829
Multicenter Study That Offers New Solutions for Paediatric Rehabilitation by Proposing a Rehabilitation Plan Based on Each Child's Needs Using New Technological and Robotic Devices, Combined Among Them.
NARecruiting
194 participants
Started: Nov 4, 2024 · Completed: Jan 31, 2027
1 condition5 sponsors6 locations
NCT06672731
BIOchemical, DEnsitometric, TEChnological and Imaging Tools to Evaluate the Bone/muscle in Children with Cerebral Palsy
NANot yet recruiting
100 participants
Started: Nov 1, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors0 locations
NCT06817746
Telehealth Intervention for Infants With Prodromes of ASD
NARecruiting
132 participants
Started: Nov 1, 2024 · Completed: Aug 31, 2027
1 condition4 sponsors4 locations
NCT06622655
Clinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy
NARecruiting
40 participants
Started: Oct 29, 2024 · Completed: Jul 31, 2026
1 condition4 sponsors6 locations
NCT06394570
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
PHASE1/PHASE2Recruiting
19 participants
Started: Sep 10, 2024 · Completed: Jul 1, 2027
1 condition2 sponsors1 location
NCT06140199
Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)
NANot yet recruiting
482 participants
Started: Aug 28, 2024 · Completed: May 31, 2032
5 conditions8 sponsors0 locations
NCT06544642
A Study to Evaluate the Effects of ASP5502 in Healthy Adults and Adults With Primary Sjögren's Syndrome
PHASE1Recruiting
132 participants
Started: Aug 21, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT06440967
A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy
PHASE3Recruiting
540 participants
Started: Jul 31, 2024 · Completed: Sep 30, 2028
1 condition1 sponsor98 locations
NCT06844877
Italian NCL Registry: a Registry for NCL as an Integration Tool for Future Therapeutic Strategies
N/ARecruiting
50 participants
Started: Jul 19, 2024 · Completed: Jul 19, 2027
1 condition3 sponsors1 location
NCT06798233
Development and Validation of a New Questionnaire for Caregivers to Assess Hip Pain in Quadriplegic Pediatric Patients: Non-Ambulatory Hip Pain Questionnaire
NARecruiting
100 participants
Started: Jul 17, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT06378372
How Does Pianistic Musical Training Influence the Development of Alzheimer's Disease?
NANot yet recruiting
20 participants
Started: Jun 1, 2024 · Completed: Jun 1, 2025
10 conditions3 sponsors1 location
NCT06171178
A Study of ASP1012 in Adults With Solid Tumors
PHASE1Active, not recruiting
15 participants
Started: May 15, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor8 locations
NCT06364696
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors
PHASE1Recruiting
175 participants
Started: Apr 16, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor7 locations
NCT05999747
A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease
PHASE3Recruiting
94 participants
Started: Mar 19, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor11 locations